Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination

Veterinary Immunology and Immunopathology

Volumn 94, Issue 1-2, 2003, Pages 47-62

  Soboll, G ^a   Horohov, D W ^b   Aldridge, B M ^a   Olsen, C W ^a   McGregor, M W ^a   Drape, R J ^c   Macklin, M D ^c   Swain, W F ^c   Lunn, D P ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c PowderJect Vaccines Inc   (United States)

Author keywords

Infectious immunity virus; Vaccination; Viral immunology

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BLOOD; CELLULAR IMMUNITY; CONTROLLED STUDY; HORSE; IMMUNOGLOBULIN PRODUCTION; INFLUENZA VIRUS; LYMPH NODE CELL; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MUCOSA CELL; NASOPHARYNX; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS INFECTION;

EQUIDAE; EQUINE INFLUENZA VIRUS; INFLUENZA VIRUS;

EID: 0038722278     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(03)00060-6     Document Type: Article

References (36)

1. Arulanandam B.P., Raeder R.H., Nedrud J.G., Bucher D.J., Le J., Metzger D.W. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J. Immunol. 166:2001;226-231.
2. Brenner C.A., Tam A.W., Nelson P.A., Engleman E.G., Suzuki N., Fry K.E., Larrick J.W. Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques. 7:1989;1096-1103.
3. Folsom R.W., Littlefield-Chabaud M.A., French D.D., Pourciau S.S., Mistric L., Horohov D.W. Exercise alters the immune response to equine influenza virus and increases susceptibility to infection. Equine. Vet. J. 33:2001;664-669.
4. Giguere S., Wilkie B.N., Prescott J.F. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 67:1999;5041-5047.
5. Johnson P.A., Conway M.A., Daly J., Nicolson C., Robertson J., Mills K.H. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J. Gen. Virol. 81:2000;1737-1745.
6. Kendal, A.P., Pereira, M.S., Skehel, J.J., 1982. Concepts and procedures for laboratory-based influenza surveillance. United States Department of Health and Human Services.
7. Klinman D.M., Sechler J.M., Conover J., Gu M., Rosenberg A.S. Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J. Immunol. 160:1998;2388-2392.
8. Larsen D.L., Dybdahl-Sissoko N., McGregor M.W., Drape B., Neumann V., Swain W.F., Lunn D.P., Olsen C.W. Co-administration of DNA encoding interleukin 6 and hemagglutinin confers protection from influenza virus challenge in mice. J. Virol. 72:1998;1704-1708.
9. Larsen D.L., Karasin A., Zuckermann F., Olsen C.W. Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet. Microbiol. 74:2000;117-131.
10. Lunn D.P., Holmes M.A., Antczak D.F. Summary report of the 2nd equine leucocyte antigen workshop, July 1995, Squaw Valley, California. Vet. Immunol. Immunopathol. 54:1996;159-161.
11. Lunn, D.P., Olsen, C.W., Soboll, G., McGregor, M.W., Drape, R., Macklin, M.D., McCabe, D.E., Swain, W.F., 1999a. Development of practical DNA vaccination strategies for use in horses. In: Wernery, U., Wade, J.F., Mumford, J.A., Kaaden, O.-R. (Eds.), Equine Infectious Diseases, VIII. Proceedings of the Eighth International Conference, Dubai, March 23-26, 1998. R & W Publications, Newmarket, pp. 38-43.
12. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R., Macklin M.D., McCabe D.E., Swain W.F., Olsen C.W. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine. 17:1999;2245-2258.
13. Lunn D.P., Hussey S., Sebring R., Rushlow K.E., Radecki S.V., Whitaker-Dowling P., Youngner J.S., Chambers T.M., Holland R.E., Horohov D.W. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in horses after induction of exercise-induced immunosuppression. J. Am. Vet. Med. Assoc. 218:2001;900-906.
14. Mbawuike I.N., Pacheco S., Acuna C.L., Switzer K.C., Zhang Y., Harriman G.R. Mucosal immunity to influenza without IgA: an IgA knockout mouse model. J. Immunol. 162:1999;2530-2537.
15. Morley P.S., Townsend H.G.G., Bodgan J.R., Haines D.M. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J. Am. Vet. Med. Assoc. 215:1999;61-66.
16. Mosmann T.R. Cytokine secretion patterns and cross-regulation of T cell subsets. Immunol. Res. 10:1991;183-188.
17. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
18. Mumford, J.A., 1992. Progress in the control of equine influenza. In: Plowright, W., Rossdale, P.D., Wade, J.F. (Eds.), Equine Infectious Diseases, VI. Proceedings of the Sixth International Conference. R & W Publications, Newmarket, pp. 207-217.
19. Nelson K.M., Schram B.R., McGregor M.W., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine. 16:1998;1306-1313.
20. Novak M., Yamamoto M., Fujihashi K., Moldoveanu Z., Kiyono H., McGhee J.R., Mestecky J. Ig-secreting and interferon-gamma-producing cells in mice mucosally immunized with influenza virus. Adv. Exp. Med. Biol. B. 371:1995;1587-1590.
21. Oehen S., Hengartner H., Zinkernagel R.M. Vaccination for disease. Science. 251:1991;195-198.
22. Okuda K., Ihata A., Watabe S., Okada E., Yamakawa T., Hamajima K., Yang J., Ishii N., Nakazawa M., Ohnari K., Nakajima K., Xin K.Q. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene. Vaccine. 19:2001;3681-3691.
23. Olsen C.W., McGregor M.W., Dybdahl-Sissoko N., Schram B.R., Nelson K.M., Lunn D.P., Macklin M.D., Swain W.F., Hinshaw V.S. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice. Vaccine. 15:1997;1149-1156.
24. Renegar K.B., Small P.A.J. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1991;1972-1978.
25. Slack J.A., Risdahl J.M., Valberg S., Murphy M.J., Schram B.R., Lunn D.P. Effects of corticosteroids on equine IgG sub-isotype responses to vaccination. Am. J. Vet. Res. 61:1997;1530-1533.
26. Soboll, G., Nelson, K.M., Leuthner, E.S., Clark, R.J., Drape, R., Macklin, M.D., Swain, W.F., Olsen, C.W., Lunn, D.P., 2003. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Vaccine. 21, 3081-3092.
27. Swiderski C.E., Klei T.R., Folsom R.W., Pourciau S.S., Chapman A., Chapman M.R., Moore R.M., McClure J.R., Taylor H.W., Horohov D.W. Vaccination against Strongylus vulgaris in ponies: comparison of the humoral and cytokine responses of vaccinates and nonvaccinates. Adv. Vet. Med. 41:1999;389-404.
28. Swiderski C.E., Klei T.R., Horohov D.W. Quantitative measurement of equine cytokine mRNA expression by polymerase chain reaction using target-specific standard curves. J. Immunol. Meth. 222:1999;155-169.
29. Swiderski C.E., Soboll G., Lunn D.P., Horohov D.W. Molecular cloning, sequencing, and expression of equine interleukin 6. Vet. Immunol. Immunopathol. 77:2000;213-220.
30. Tamura S., Funato H., Hirabayashi Y., Kikuta K., Suzuki Y., Nagamine T., Aizawa C., Nakagawa M., Kurata T. Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine. 8:1990;479-485.
31. Tamura S., Funato H., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., Kurata T. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur. J. Immunol. 21:1991;1337-1344.
32. Tomoda T., Morita H., Kurashige T., Maassab H.F. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-gamma production and local IgA response. Vaccine. 13:1995;185-190.
33. Traub-Dargatz J.L., Salman M.D., Voss J.L. Medical problems of adult horses, as ranked by equine practitioners. J. Am. Vet. Med. Assoc. 198:1991;1745-1747.
34. Watabe S., Xin K.Q., Ihata A., Liu L.J., Honsho A., Aoki I., Hamajima K., Wahren B., Okuda K. Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine. 19:2001;4434-4444.
35. Wong J.P., Zabielski M.A., Schmaltz F.L., Brownlee G.G., Bussey L.A., Marshall K., Borralho T., Nagata L.P. DNA vaccination against respiratory influenza virus infection. Vaccine. 19:2001;2461-2467.
36. Zhao S., Consoli U., Arececi R., Pfeifer J., Dalton W., Andreeff M. Semi-automated PCR method for quantitating MDR1 expression. Biotechniques. 21:1996;726-731.